OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,338,627	2,834,660	355,531	233,568	278,859	561,830
Market Cap Growth	160.20%	697.30%	52.22%	-16.24%	-50.37%	-17.52%
Enterprise Value	2,253,738	2,728,026	392,701	247,386	238,494	524,125
Last Close Price	115200.00	140400.00	19260.00	14580.00	20350.00	41000.00
PS Ratio	135.47	193.27	62.63	13.69	29.92	152.91
PB Ratio	16.09	18.89	19.25	4.64	4.21	28.95
P/TBV Ratio	16.50	19.36	22.02	4.92	4.48	34.29
EV/Sales Ratio	130.56	186.00	69.17	14.50	25.59	142.64
Debt / Equity Ratio	0.15	0.16	2.12	0.78	0.67	1.92
Net Debt / Equity Ratio	-0.60	-0.73	1.45	0.27	-0.27	-0.64
Net Debt / EBITDA Ratio	2.87	3.97	-0.95	-0.86	0.88	0.55
Net Debt / FCF Ratio	3.94	6.37	-0.64	-0.45	0.54	0.61
Asset Turnover	0.14	0.11	0.07	0.14	0.09	0.04
Inventory Turnover	0.62	0.70	0.49	0.28	0.40	0.51
Quick Ratio	5.50	6.51	0.45	4.71	1.59	1.24
Current Ratio	6.59	6.61	0.52	4.90	1.65	1.29
Return on Equity (ROE)	-14.29%	-18.68%	-118.18%	-32.78%	-65.68%	-90.11%
Return on Assets (ROA)	-15.92%	-14.05%	-22.20%	-9.65%	-12.75%	-18.33%
Return on Capital Employed (ROCE)	-19.60%	-17.20%	-75.10%	-18.90%	-24.00%	-52.30%
Earnings Yield	-0.52%	-0.56%	-11.44%	-8.18%	-6.99%	-5.29%
FCF Yield	-0.94%	-0.60%	-11.68%	-12.84%	-11.80%	-3.62%
Buyback Yield / Dilution	-17.96%	-16.77%	-16.73%	-5.30%	-0.13%	-4.06%